524731 — Jenburkt Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹4.56bn
- IN₹3.80bn
- IN₹1.42bn
- 86
- 35
- 74
- 76
Annual cashflow statement for Jenburkt Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 211 | 165 | 223 | 246 | 260 |
| Depreciation | |||||
| Non-Cash Items | -35.2 | 15.2 | 34.3 | 44.6 | 62.9 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -49 | -6 | -182 | -143 | -265 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 150 | 195 | 94 | 171 | 81.2 |
| Capital Expenditures | -45.5 | -11.5 | -30.5 | -21 | -25.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 16.8 | -176 | 17.2 | 47.2 | 19.7 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -28.8 | -188 | -13.3 | 26.2 | -5.8 |
| Financing Cash Flow Items | -22.5 | -2.04 | -3.41 | -5.17 | -2.5 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -108 | -7.14 | -55.3 | -210 | -70.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13.1 | -0.403 | 25.4 | -13.7 | 4.66 |